Sort   by:  
 Page size 
UnknownA pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer.
Not available
S-EPMC6947904 | biostudies-literature
UnknownSorcin regulates alveolarization and airway tissue remodeling during lung morphogenesis.
Not available
S-EPMC12569328 | biostudies-literature
UnknownCancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
Not available
S-EPMC4798739 | biostudies-literature
UnknownmiR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours.
Not available
S-EPMC3494877 | biostudies-literature
UnknownLung Cancer Organoids: The Rough Path to Personalized Medicine.
Not available
S-EPMC9367558 | biostudies-literature
UnknownUropathogenic Escherichia coli (UPEC) that hides its identity: features of LC2 and EC73 strains from recurrent urinary tract infections
Not available
S-EPMC12376328 | biostudies-literature
UnknownHistone deacetylase inhibition enhances self renewal and cardioprotection by human cord blood-derived CD34 cells.
Not available
S-EPMC3138768 | biostudies-literature
UnknownBody mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.
Not available
S-EPMC5902232 | biostudies-literature
UnknownA Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.
Not available
S-EPMC6220933 | biostudies-literature
UnknownOrganoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
Not available
S-EPMC6393468 | biostudies-literature
Sort   by:  
 Page size